Benefits
Calm and everyday stress support
In a Cochrane review of randomized, double-blind, placebo-controlled trials (Pittler 2003), kava extract lowered anxiety scores on the Hamilton Anxiety Scale versus placebo. That clinical finding is reported here as trial evidence, not as a treatment claim; as a supplement, kava is used to support a sense of calm and to ease everyday stress. Given the serious liver-safety concern noted in the warnings below, kava is not a substitute for medical evaluation or care of a diagnosed anxiety disorder.
Sleep quality improvement
Kavalactones improve sleep quality and reduce sleep onset latency through GABAergic and anxiolytic mechanisms — helping particularly anxiety-driven sleep disturbances. Because kava's calming, GABAergic activity can ease anxiety-driven sleeplessness, it may support more restful sleep; this is largely inferred from its anxiolytic mechanism rather than from dedicated sleep trials in the cited evidence.
Muscle relaxation
Kavalactones produce skeletal muscle relaxation through sodium channel blockade and spinal cord modulation, reducing muscle tension associated with anxiety and stress. This relaxant effect complements the anxiolytic activity for comprehensive tension and stress relief.
Mechanism of action
GABA-A receptor positive allosteric modulation
Kavalactones, particularly kavain and dihydrokavain, bind the GABA-A receptor complex and enhance inhibitory GABAergic neurotransmission — similar in principle to benzodiazepines but at different binding sites and with lower efficacy, producing milder anxiolytic effects without the sedation and dependency of benzodiazepines.
Sodium and calcium channel blockade
Kavalactones block voltage-gated sodium and calcium channels in neurons, reducing neuronal excitability and producing muscle-relaxant and local anesthetic effects. This membrane-stabilizing mechanism contributes to both anxiolytic and muscle-relaxant properties.
MAO-B inhibition and dopamine modulation
Yangonin inhibits monoamine oxidase B (MAO-B), mildly increasing dopamine availability. This dopaminergic effect may contribute to kava's mood-enhancing properties beyond the GABA-A mechanism.
Clinical trials
Cochrane evidence review of 12 randomized, double-blind, placebo-controlled trials examining kava extract for treatment of anxiety. (Pittler MH, Ernst E; Cochrane Database Syst Rev)
Pooled across 12 clinical trials.
Kava extract significantly more effective than placebo for reducing anxiety symptoms (Hamilton Anxiety Scale). Consistent positive effects across trials. Critical hepatotoxicity history: from 1998-2002, multiple cases of severe hepatotoxicity (acute liver failure, transplants, deaths) led to kava bans in Germany, France, Switzerland, and several other countries. FDA issued consumer advisory (2002). Many countries reversed bans by 2014-2015 after analysis suggested specific extraction methods (acetone/ethanol from non-noble cultivars or aerial parts) were responsible. Traditional water-extracted kava from noble cultivars (Vanuatu, Fiji) appears safer. Modern recommendation: water-extracted noble kava root only; avoid alcohol/acetone extracts; limit duration of use; monitor liver function.